TFG Advisers’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,001
| Closed | -$310K | – | 199 |
|
|
2022
Q1 | $310K | Sell |
8,001
-263
| -3% | -$10.2K | 0.14% | 150 |
|
|
2021
Q4 | $484K | Sell |
8,264
-407
| -5% | -$23.8K | 0.21% | 119 |
|
|
2021
Q3 | $514K | Buy |
8,671
+274
| +3% | +$16.2K | 0.25% | 105 |
|
|
2021
Q2 | $729K | Sell |
8,397
-147
| -2% | -$12.8K | 0.35% | 81 |
|
|
2021
Q1 | $704K | Sell |
8,544
-74
| -0.9% | -$6.1K | 0.36% | 77 |
|
|
2020
Q4 | $783K | Buy |
8,618
+1,111
| +15% | +$101K | 0.41% | 70 |
|
|
2020
Q3 | $300K | Buy |
+7,507
| New | +$300K | 0.17% | 134 |
|
|
2020
Q1 | – | Sell |
-2,184
| Closed | -$42K | – | 244 |
|
|
2019
Q4 | $42K | Buy |
+2,184
| New | +$42K | 0.02% | 284 |
|